Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (8)
Journal Articles (2)

Journal

Investigative Ophthalmology & Visual Science (9)
Translational Vision Science & Technology (1)

Article Type

ARVO Annual Meeting Abstract (8)
Glaucoma (2)

Topics

Eye Anatomy and Disorders (2)
Pharmacology (2)
Glaucoma (1)
Translational Research (1)

Tags

administration, topical (1)
agonists (1)
antihypertensive agents (1)
aqueous humor (1)
body tissue (1)
cercopithecidae (1)
cornea (1)
drug or chemical tissue distribution (1)
eye (1)
intraocular pressure (1)

Specify Date Range

From: To: Apply

Showing 1 – 10 of 10

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Glaucoma November 2024

Ocular Tissue Distribution of Omidenepag Isopropyl in Rabbits and Cynomolgus Monkeys

PDF

Kenzo Yamamura; Hidetoshi Mano; Masahiro Fuwa; Ryo Iwamura; Noriko Odani-Kawabata
TAGS: cercopithecidae, drug or chemical tissue distribution, macaca fascicularis, omidenepag, oryctolagus cuniculus, radioactivity, cornea, eye, aqueous humor, administration, topical
Trans. Vis. Sci. Tech.. 2024; 13(11):6. https://doi.org/10.1167/tvst.13.11.6

ARVO Annual Meeting Abstract July 2019

Effects of Omidenepag Isopropyl, a Selective EP2 Receptor Agonist, on Iris Pigmentation

Yoshihiko Esaki; Takazumi Taniguchi; Ryo Iwamura; Kenji Yoneda; Noriko Odani-Kawabata; Hidetoshi Mano; Takeshi Matsugi; Naveed Kamal Shams

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3780.

ARVO Annual Meeting Abstract July 2019

Effects of Omidenepag, a Selective EP2 Receptor Agonist on Adipocyte Differentiation

Yasuko Yamamoto; Takazumi Taniguchi; Masahiro Ota; Ryo Iwamura; Kenji Yoneda; Noriko Odani-Kawabata; Takeshi Matsugi; Naveed Kamal Shams

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3781.

ARVO Annual Meeting Abstract July 2018

Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-induced Ocular Hypertensive Monkeys

Masahiro Fuwa; Carol B Toris; Shan Fan; Takazumi Taniguchi; Masaki Ichikawa; Noriko Odani-Kawabata; Ryo Iwamura; Kenji Yoneda; Takeshi Matsugi; Naveed Kamal Shams; Jin-Zhong Zhang

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2717.

ARVO Annual Meeting Abstract July 2018

Effects of a selective EP2 receptor agonist, omidenepag isopropyl, on eyelash growth in mice

Yoshihiko Esaki; Osamu Katsuta; Takazumi Taniguchi; Ryo Iwamura; Kenji Yoneda; Noriko Odani-Kawabata; Mitsunori Maeda; Hidetoshi Mano; Takeshi Matsugi; Naveed Kamal Shams

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2718.

Glaucoma January 2018

Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent

PDF

Tomoko Kirihara; Takazumi Taniguchi; Kenzo Yamamura; Ryo Iwamura; Kenji Yoneda; Noriko Odani-Kawabata; Atsushi Shimazaki; Takeshi Matsugi; Naveed Shams; Jin-Zhong Zhang
TAGS: agonists, antihypertensive agents, intraocular pressure, pharmacology, prostaglandins
Invest. Ophthalmol. Vis. Sci.. 2018; 59(1):145-153. https://doi.org/10.1167/iovs.17-22745

ARVO Annual Meeting Abstract June 2017

Pharmacokinetics, Safety and IOP Lowering Profiles of omidenepag isopropyl, a Selective EP2 Agonist in Healthy Japanese and Caucasian Volunteers (Phase I Study)

Makoto Aihara; Fenghe Lu; Hisashi Kawata; Yuki Tanaka; Kenzo Yamamura; Ryo Iwamura; Kenji Yoneda; Noriko Odani; Naveed Shams

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2104.

ARVO Annual Meeting Abstract June 2017

Omidenepag isopropyl, a selective EP2 agonist, shows additive intraocular pressure (IOP)-lowering effects when used concomitantly with existing anti-glaucoma drugs in animal models

Takazumi Taniguchi; Tomoko Kirihara; Miki Takahashi; Ryo Iwamura; Kenji Yoneda; Noriko Odani; Atsushi Shimazaki; Masaki Ichikawa; Jin-Zhong Zhang

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2105.

ARVO Annual Meeting Abstract June 2015

Safety and Efficacy of DE-117, a Selective EP 2 Agonist in a Phase 2a Study

Nnenna Ihekoromadu; Fenghe Lu; Ryo Iwamura; Kenji Yoneda; Noriko Kawabata-Odani; Naveed Kamal Shams

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5708.

ARVO Annual Meeting Abstract June 2015

DE-117, a selective EP2 agonist, lowered intraocular pressure in animal models

Tomoko Kirihara; Ryo Iwamura; Kenji Yoneda; Noriko Kawabata-Odani; Atsushi Shimazaki; Kouichi Kawazu

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5709.

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2025 Association for Research in Vision and Ophthalmology.

Access Provided By:
MIT Libraries

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept